{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:48:39Z","timestamp":1773114519829,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1023\/a:1005882314735","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T23:56:21Z","timestamp":1040514981000},"page":"47-53","source":"Crossref","is-referenced-by-count":11,"title":["Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer"],"prefix":"10.1007","volume":"45","author":[{"given":"A.M.","family":"Murad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.C.","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Morici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.","family":"Ferreira-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schwartsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"134947_CR1","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/1097-0142(19830615)51:12+<2553::AID-CNCR2820511329>3.0.CO;2-7","volume":"51","author":"CI Henderson","year":"1983","unstructured":"Henderson CI: Chemotherapy of breast cancer: a general overview. Cancer 51: 2553\u20132559, 1983","journal-title":"Cancer"},{"key":"134947_CR2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0277-5379(87)90251-3","volume":"23","author":"G Schwartsmann","year":"1987","unstructured":"Schwartsmann G, Pinedo HM: Clinical trials in advanced breast cancer. Eur J Cancer 23: 595\u2013597, 1987","journal-title":"Eur J Cancer"},{"key":"134947_CR3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/1097-0142(19900915)66:14+<1439::AID-CNCR2820661421>3.0.CO;2-M","volume":"66","author":"IC Henderson","year":"1990","unstructured":"Henderson IC, Garber JE, Breitmeyer JB: Comprehensive management of disseminated breast cancer. Cancer 66: 1439\u20131448, 1990","journal-title":"Cancer"},{"key":"134947_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/np50067a001","volume":"53","author":"DGI Kingston","year":"1990","unstructured":"Kingston DGI, Samaranayake G, Ivey CA: The chemistry of paclitaxel, a clinically useful anticancer agent. J Nat Prod 53: 1\u201312, 1990","journal-title":"J Nat Prod"},{"key":"134947_CR5","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/ja00738a045","volume":"893","author":"MC Wani","year":"1971","unstructured":"Wani MC, Taylor HL, Wall ME et al.: Plant antitumor agents VI. The isolation and structure of paclitaxel, a novel antileukemic and antitumor agent from taxus brevifolia. J Am Chem Soc 893: 2325\u20132327, 1971","journal-title":"J Am Chem Soc"},{"key":"134947_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-111-4-273","volume":"11","author":"WP McGuire","year":"1989","unstructured":"McGuire WP, Rowinsky EK, Rosenshein NB et al.: Paclitaxel: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Int Med 11: 273\u2013279, 1989","journal-title":"Ann Int Med"},{"key":"134947_CR7","first-page":"294","volume":"11","author":"A Chang","year":"1992","unstructured":"Chang A, Kim K, Glick J et al.: Phase II study of paclitaxel in patients with stage IV nonsmall cell lung cancer. The Eastern Cooperative Study Group study results (abst). Proc Am Soc Clin Oncol 11: 294, 1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"134947_CR8","unstructured":"Forastiere AA, Adams G, Neuberg D et al.: Phase II trial of paclitaxel in head and neck cancer: an Eastern Cooperative Study Group study (abst). Second National Cancer Institute Workshop on Paclitaxel and Taxus. Alexandria, VA 1992"},{"key":"134947_CR9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/83.24.1797-a","volume":"83","author":"FA Holmes","year":"1991","unstructured":"Holmes FA, Walters RS, Theriault RL et al.: Phase II trial of paclitaxel, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797\u20131805, 1991","journal-title":"J Natl Cancer Inst"},{"key":"134947_CR10","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.1995.13.10.2575","volume":"13","author":"AD Seidman","year":"1995","unstructured":"Seidman AD, Tiersten A, Hudis C et al.: Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol 13: 2575\u20132581, 1995","journal-title":"J Clin Oncol"},{"key":"134947_CR11","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1993.11.10.1943","volume":"11","author":"BS Reichman","year":"1993","unstructured":"Reichman BS, Seidman AD, Crown JPA et al.: Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 11: 1943\u20131951, 1993","journal-title":"J Clin Oncol"},{"key":"134947_CR12","first-page":"161","volume":"15","author":"FA Holmes","year":"1993","unstructured":"Holmes FA, Valero V, Walters RS et al.: The M.D. Anderson Cancer Center experience with paclitaxel in metastatic breast cancer. Monogr Natl Cancer Inst 15: 161\u2013169, 1993","journal-title":"Monogr Natl Cancer Inst"},{"issue":"4Suppl8","key":"134947_CR13","first-page":"3","volume":"22","author":"AD Seidman","year":"1995","unstructured":"Seidman AD, Hudis CA, Norton L: Memorial Sloan-Kettering Cancer Center Experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy. Semin Oncol 22(4 Suppl 8): 3\u20138, 1995","journal-title":"Semin Oncol"},{"issue":"6Suppl12","key":"134947_CR14","first-page":"36","volume":"19","author":"GN Hortobagyi","year":"1992","unstructured":"Hortobagyi GN: Activity of ifosfamide in breast cancer. Semin Oncol 19(6 Suppl 12): 36\u201341, 1992","journal-title":"Semin Oncol"},{"key":"134947_CR15","first-page":"56","volume":"16","author":"R Becher","year":"1989","unstructured":"Becher R, Hofeler H, Kloke O et al.: Isofamide, methotrexate and 5-FU in advanced pretreated breast cancer. Semin Oncol 16: 56\u201359, 1989","journal-title":"Semin Oncol"},{"key":"134947_CR16","first-page":"59","volume":"20","author":"KK Fields","year":"1993","unstructured":"Fields KK, Effenbein GJ, Perkins JB et al.: Two novel high-dose treatment regimens for metastatic breast cancer \u2014 ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities. Semin Oncol 20: 59\u201366, 1993","journal-title":"Semin Oncol"},{"key":"134947_CR17","series-title":"WHO Offset publication","volume-title":"Handbook for Reporting Results of Cancer Treatment","author":"WHO","year":"1979","unstructured":"WHO: Handbook for Reporting Results of Cancer Treatment. WHO Offset publication No 48. World Health Organization, Geneva, Switzerland, 1979"},{"key":"134947_CR18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0277-5379(91)90317-7","volume":"9","author":"G Schwartsmann","year":"1991","unstructured":"Schwartsmann G, Wanders J, Koier IJ, Franklin HR, Dalesio O, Hornstra HW, van Glabbeke, Renard J, van Oosterom AT, Kaye SB, Pinedo HM: EORTC New Drug Development Office coordinating and monitoring program for phase I and II trails with new anticancer drugs. Eur J Cancer 9: 1162\u20131168, 1991","journal-title":"Eur J Cancer"},{"key":"134947_CR19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","volume":"13","author":"EA Gehan","year":"1961","unstructured":"Gehan EA: The determination of the number of patients required in a follow up trial of a new chemotherapy agent. J Chronic Dis 13: 346\u2013353, 1961","journal-title":"J Chronic Dis"},{"key":"134947_CR20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457\u2013481, 1958","journal-title":"J Am Stat Assoc"},{"key":"134947_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0169-2607(88)90086-7","volume":"27","author":"N Campos-Filho","year":"1988","unstructured":"Campos-Filho N, Franco ELF: Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Comp Meth Prog Biomed 27: 223\u2013228, 1988","journal-title":"Comp Meth Prog Biomed"},{"key":"134947_CR22","first-page":"163","volume":"70","author":"L Norton","year":"1986","unstructured":"Norton L, Simon R: The Norton-Simon hypothesis revisited. Cancer Treat Rep 70: 163\u2013169, 1986","journal-title":"Cancer Treat Rep"},{"key":"134947_CR23","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1200\/JCO.1995.13.11.2688","volume":"13","author":"L Gianni","year":"1955","unstructured":"Gianni L, Munzone E, Capri G et al.: Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer. High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 13: 2688\u20132699, 1955","journal-title":"J Clin Oncol"},{"key":"134947_CR24","first-page":"125","volume":"15","author":"G Schwartsmann","year":"1996","unstructured":"Schwartsmann G, Menke CH, Caleffi M, Xavier N, Ferreira Filho AF, Schunemann H, Koya R, Stroda PR, Pohlmann P, Venegas LF, Kalakun L: Phase II trial of paclitaxel, plus doxorubicin plus G-CSF in patients with metastatic breast cancer. Proc Am Soc Clin Oncol 15: 125, 1996 (abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"134947_CR25","doi-asserted-by":"crossref","unstructured":"Klaassen U, Wilke H, Philippou Pari C et al.: Phase I\/II study with paclitaxel in combination with weekly high-dose 5-FU\/folonic acid in the treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 15 (abstr 186), 1995","DOI":"10.1016\/0959-8049(95)95613-B"},{"issue":"Suppl1","key":"134947_CR26","first-page":"89","volume":"37","author":"AM Murad","year":"1996","unstructured":"Murad AM, Quirino RM, Morici AM et al.: Phase II trial of the use of paclitaxel and ifosfamide in heavily pre-treated patients with metastatic breast cancer. Breast Cancer Res Treat 37: 89, 1996 Abstract (Suppl 1)","journal-title":"Breast Cancer Res Treat"},{"key":"134947_CR27","first-page":"92","volume":"13","author":"CJ Rosenthal","year":"1994","unstructured":"Rosenthal CJ, Ibrahim A, Rambhia H et al.: Paclitaxel mitoxantrone salvage therapy in metastatic carcinoma of the breast-Phase I\/II study. Proc Am Soc Clin Oncol 13: 92, 1994 (abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"134947_CR28","first-page":"140","volume":"14","author":"DM Paul","year":"1995","unstructured":"Paul DM, Garrett AM, Meshad M et al.: A phase II trial of paclitaxel, 5-fluorouracil and leucovorin (TFL) in metastatic breast cancer. Proc Am Soc Clin Oncol 14: 140, 1995 (abstr)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"134947_CR29","first-page":"97","volume":"15","author":"AM Murad","year":"1996","unstructured":"Murad AM, Tinoco LA, Schwartsmann G, Amorim WC: Phase II trial of the use of paclitaxel and ifosfamide in heavily pre-treated patients with metastatic breast cancer. Proc Am Soc Clin Oncol 15: 97, 1996","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005882314735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005882314735\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1005882314735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005882314735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:31:50Z","timestamp":1750480310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005882314735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["134947"],"URL":"https:\/\/doi.org\/10.1023\/a:1005882314735","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}